- $953.76m
- $1.02bn
- $695.24m
- 95
- 37
- 84
- 84
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 25.61 | ||
| PEG Ratio (f) | 0.86 | ||
| EPS Growth (f) | 42.52% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.43 | ||
| Price to Tang. Book | 34.94 | ||
| Price to Free Cashflow | 119.51 | ||
| Price to Sales | 1.39 | ||
| EV to EBITDA | 22.66 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.44% | ||
| Return on Equity | 11.28% | ||
| Operating Margin | 5.65% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 390.95 | 439.69 | 473.24 | 544.89 | 695.24 | 848.94 | 908.76 | 15.48% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +619.34 | -61.03 | +108.06 | -21.29 | +65.16 | +71.65 | +14.29 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through home health and hospice agencies and senior living communities located throughout Arizona, California, Colorado, Connecticut, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. Its segments include home health and hospice services, and senior living services. The home health and hospice services segment includes its home health, hospice and home care businesses. Its home health services provide care after surgery or when illness or health conditions require additional assistance. The senior living services segment includes the operation of assisted living, independent living and memory care communities. Its independent living communities are designed for active individuals or couples.
Directors
- Daniel Walker CHM (43)
- Brent Guerisoli PRE (40)
- Jennifer Freeman CFO (52)
- John Gochnour COO (38)
- Derek Bunker EVP (33)
- Christopher Christensen DRC (52)
- Stephen Covey IND (58)
- Scott Lamb IND (58)
- Gregory Morris IND
- John Nackel IND (69)
- Barry Smith IND (67)
- JoAnne Stringfield IND (62)
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- January 24th, 2019
- Public Since
- September 19th, 2019
- No. of Shareholders
- 71
- No. of Employees
- 7,000
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
NASDAQ Global Select Market- Shares in Issue
- 34,468,981
- Address
- 1675 E Riverside Dr Ste 150, EAGLE, 83616-7584
- Web
- https://www.pennantgroup.com/
- Phone
- +1 2089576025
- Auditors
- Deloitte & Touche LLP
Latest News for PNTG
Upcoming Events for PNTG
Pennant Group Inc Annual Shareholders Meeting
Q2 2025 Pennant Group Inc Earnings Release
Q3 2025 Pennant Group Inc Earnings Release
Similar to PNTG
Acadia Healthcare
NASDAQ Global Select Market
Addus HomeCare
NASDAQ Global Select Market
Alignment Healthcare
NASDAQ Global Select Market
Amedisys
NASDAQ Global Select Market
Aveanna Healthcare Holdings
NASDAQ Global Select Market
FAQ
As of Today at 04:36 UTC, shares in Pennant are trading at $30.22. This share price information is delayed by 15 minutes.
Shares in Pennant last closed at $30.22 and the price had moved by +34.85% over the past 365 days. In terms of relative price strength the Pennant share price has outperformed the S&P500 Index by +20.02% over the past year.
The overall consensus recommendation for Pennant is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out morePennant does not currently pay a dividend.
Pennant does not currently pay a dividend.
Pennant does not currently pay a dividend.
To buy shares in Pennant you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $30.22, shares in Pennant had a market capitalisation of $1.04bn.
Here are the trading details for Pennant:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: PNTG
Based on an overall assessment of its quality, value and momentum Pennant is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Pennant is $33.00. That is 9.2% above the last closing price of $30.22.
Analysts covering Pennant currently have a consensus Earnings Per Share (EPS) forecast of $1.12 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pennant. Over the past six months, its share price has underperformed the S&P500 Index by -4.89%.
As of the last closing price of $30.22, shares in Pennant were trading +3.67% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Pennant PE ratio based on its reported earnings over the past 12 months is 25.61. The shares last closed at $30.22.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Pennant's management team is headed by:
- Daniel Walker - CHM
- Brent Guerisoli - PRE
- Jennifer Freeman - CFO
- John Gochnour - COO
- Derek Bunker - EVP
- Christopher Christensen - DRC
- Stephen Covey - IND
- Scott Lamb - IND
- Gregory Morris - IND
- John Nackel - IND
- Barry Smith - IND
- JoAnne Stringfield - IND